Among these CTAs, osteosarcomas tended to express MAGE‐A4 (40%), and leiomyosarcomas (26.92%) and UPS (47.62%) tended to express PRAME, while there was no significant difference in the expression rates of these four CTAs in liposarcoma. The gene discussed is MAGEA4; the disease is leiomyosarcoma.